Key result
Higher SPECT ischemia and lower eGFR are strongly linked to increased 5-year MACCRE in CKD.
Why the study?
Are summed difference score and eGFR reliable prognostic markers for predicting MACCRE over 5 years in patients with chronic kidney disease?
Cohort (n=311)
Yes
Are summed difference score and eGFR reliable prognostic markers for predicting MACCRE over 5 years in patients with chronic kidney disease?
Answers are grounded in this paper and cite their sources.
In patients with chronic kidney disease, summed difference score on stress SPECT and eGFR are reliable prognostic markers for major adverse cardiovascular, cerebrovascular, and renal events over 5 years.
OBJECTIVE: Patients with chronic kidney disease (CKD) have an increased risk of adverse cardio-cerebrovascular events. The purpose of this study is to evaluate the prognostic predictors over 5 years in patients with CKD including haemodialysis. METHODS: In this multicenter, prospective cohort study performed with the Gunma-CKD SPECT Study protocol, 311 patients with CKD [estimated glomerular filtration rate (eGFR) < 60 min/ml/1.73 m 2 ], including 50 patients on haemodialysis, undergoing stress Tc-99m-tetrofosmin SPECT for suspected ischaemic heart disease were followed for 5 years. MACCRE was evaluated, and summed stress score, summed rest score, summed difference score (SDS), left ventricular end-diastolic volume (LVEDV), end-systolic volume (LVESV) and ejection fraction (LVEF) were evaluated by electrocardiogram-gated SPECT. RESULTS: Of the 311 patients, 268 were followed for 5 years, and of those patients, 126 experienced MACCRE: cardiac death, n = 15; sudden death, n = 5, nonfatal myocardial infarction, n = 5; hospitalization for heart failure, n = 16; cerebrovascular accident, n = 9; revascularization, n = 49; renal events (haemodialysis initiation/kidney transplantation), n = 20 and other cardiovascular events, n = 7. In univariate Cox analysis, eGFR ( P < 0.0001), haemoglobin ( P = 0.001), SDS ( P = 0.0001), LVEDV ( P = 0.002), LVESV ( P = 0.0003) and LVEF ( P < 0.0001) were associated with MACCRE, and in multivariate Cox analysis, eGFR ( P = 0.014) and SDS ( P = 0.002) were strongly associated with MACCRE. In Kaplan-Meier analysis, the event-free survival rate for MACCRE was better in patients with SDS below 3 than in those with SDS of 3 or higher ( P < 0.0001, log-rank test) and in patients with eGFR of 18 or higher than in those with eGFR below 18 ( P < 0.0001, log-rank test). CONCLUSION: In patients with CKD, SDS and eGFR are reliable prognostic markers for the occurrence of MACCRE over 5 years.
No takes yet. Share an insight, caveat, or question.
Toyama et al. (2025) conducted a cohort in Chronic kidney disease (n=311). Summed difference score (SDS) ≥3 and eGFR <18 vs. SDS <3 and eGFR ≥18 was evaluated on Major adverse cardiovascular, cerebrovascular, and renal events (MACCRE) (p=<0.0001). In patients with chronic kidney disease, a summed difference score ≥3 on stress SPECT and an eGFR <18 were strongly associated with a higher risk of MACCRE over 5 years (P<0.0001).
Synapse has enriched 10 related papers. Consider them for comparative context: